$Biolidics(8YY.SI) IF you believe and like this latest news (which I do partly), believe $Singapore-eDev(40V.SI) too, I think this would be a laggard play tomorrow. If BIO HEATS up fast, this may run.

 

This is what Bio says: ACE2 is a cellular receptor for coronaviruses such as SARS and novel coronavirus SARS-CoV-2. Spike proteins from these coronaviruses recognize and bind to ACE2 on the surface of target cells (e.g. lung cells), allowing the virus to enter cells and infecting the person. Most commercially available serology tests against COVID-19, including the Company&rsquo s COVID-19 Antibody Test Kit launched on 30 March 2020, detects the IgG and IgM antibodies (a group of antibodies produced by the body in response to the infection of SARS-CoV-2 virus). As such, these serology tests which detect the presence of IgG and IgM are currently used only as an assistive tool in the detection of COVID-19, and they are not able to detect specific antibodies that bind to the SARS-CoV-2 virus which interfere with its ability to infect target cells.

 

 

This is what SeD says: These in vitro results confirm the predictions of advanced computational molecular docking which showed that Equivir and Linebacker had binding with high affinity to the COVID-19 helicase and protease. Equivir and Linebacker also cause transformational changes to the ACE-2 receptor which interferes with the ability of the virus to interact with the receptor and infect the host cell. Binding affinity for components of 3F Biofragrance was also observed in molecular docking.